Vanguard Capital Management
COLL icon

Vanguard Capital Management’s Collegium Pharmaceutical COLL Stock Holding History

Vanguard Capital Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50M Buy
1,381,261
+47,269
+4% +$1.62M ﹤0.01% 1949
2026
Q1 		$44.1M Buy
+1,333,992
New +$56.5M ﹤0.01% 1919

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management's COLL Position: Q2 2026 in Review

Vanguard Capital Management increased its Collegium Pharmaceutical (COLL) stake by 3.5% in Q2 2026, buying an estimated $1.62M and bringing the position to 1,381,261 shares worth $50M. The position accounts for ﹤0.01% of the portfolio, ranked #1949.

Vanguard Capital Management first reported a position in COLL in Q1 2026 and has held it in 2 quarters since. 277 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Vanguard Capital Management held 1,381,261 shares of Collegium Pharmaceutical worth $50M as of Q2 2026.
  • Vanguard Capital Management bought 47,269 Collegium Pharmaceutical shares in Q2 2026, an estimated $1.62M.
  • Collegium Pharmaceutical made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #1949 holding.
  • Vanguard Capital Management first reported a position in Collegium Pharmaceutical in Q1 2026 and has held it in 2 quarters since.
  • 277 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.